Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
To accelerate the development of next-generation radioconjugates to treat cancer
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Additional capacity broadens Grace’s fine chemical capabilities for API production
Both organisations enter into a long- term collaboration to expand patient access in India
Sen spent a decade with Biocon and held various key roles,
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
Acquisition of exclusive commercialization rights for European markets
Subscribe To Our Newsletter & Stay Updated
